Our Perspectives

THREAD Blog

The real value of eConsent in clinical trials
Insights Leslie Yates Insights Leslie Yates

The real value of eConsent in clinical trials

There is still a reluctance to adopt more innovative approaches among sponsors and clinical research organizations (CROs) because sometimes the clinical trial model just isn't compatible with those innovations and other times, they feel it is too complicated to introduce different technologies into clinical trials. Adding eSource into your clinical trial is one way to get started with decentralized technologies and the potential burdens are outweighed by the value…

Read More